Home
Forms Library
Sapropterin for BH4 deficiency Initial and continuing PBS authority application

Sapropterin for BH4 deficiency Initial and continuing PBS authority application 2025

Sapropterin for BH4 deficiency Initial and continuing PBS authority application Preview on Page 1

Show details

4.8 out of 5

231 votes

The document outlines the process for applying for initial and continuing Pharmaceutical Benefits Scheme (PBS) authority for sapropterin treatment in patients with hyperphenylalaninaemia (HPA) due to tetrahydrobiopterin (BH4) deficiency. It details the necessary information required for application, including patient eligibility criteria, required attachments, and submission guidelines. The document emphasizes that all applications must be submitted in writing and provides contact information for further assistance.

Here's how it works

01. Edit your form online

Type text, add images, blackout confidential details, add comments, highlights and more.

02. Sign it in a few clicks

Draw your signature, type it, upload its image, or use your mobile device as a signature pad.

03. Share your form with others

Send it via email, link, or fax. You can also download it, export it or print it out.

The easiest way to modify Sapropterin for BH4 deficiency Initial and continuing PBS authority application in PDF format online

Ease of Setup

DocHub User Ratings on G2

Ease of Use

DocHub User Ratings on G2

Handling documents with our feature-rich and intuitive PDF editor is easy. Follow the instructions below to fill out Sapropterin for BH4 deficiency Initial and continuing PBS authority application online quickly and easily:

Log in to your account. Log in with your email and password or create a free account to try the product before upgrading the subscription.
Import a document. Drag and drop the file from your device or add it from other services, like Google Drive, OneDrive, Dropbox, or an external link.
Edit Sapropterin for BH4 deficiency Initial and continuing PBS authority application. Effortlessly add and highlight text, insert images, checkmarks, and icons, drop new fillable areas, and rearrange or delete pages from your document.
Get the Sapropterin for BH4 deficiency Initial and continuing PBS authority application completed. Download your adjusted document, export it to the cloud, print it from the editor, or share it with other participants via a Shareable link or as an email attachment.

Benefit from DocHub, the most straightforward editor to quickly manage your documentation online!

See more Sapropterin for BH4 deficiency Initial and continuing PBS authority application versions

We've got more versions of the Sapropterin for BH4 deficiency Initial and continuing PBS authority application form. Select the right Sapropterin for BH4 deficiency Initial and continuing PBS authority application version from the list and start editing it straight away!

Versions	Form popularity	Fillable & printable
2015	4.8 Satisfied (231 Votes)

be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.

What is the brand name for sapropterin?

INDICATIONS AND USAGE Kuvan (sapropterin dihydrochloride) is indicated to reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive Phenylketonuria (PKU). Kuvan is to be used in conjunction with a Phe-restricted diet.

What is the use of sapropterin tablet?

Sapropterin is used to lower phenylalanine levels in the blood of patients with phenylketonuria (PKU). High levels of phenylalanine (an amino acid) in the blood can cause severe brain damage, including severe mental ation, seizures, tremors, or decreased learning ability.

What are the indications for 5fu?

Fluorouracil injection is indicated in the palliative management of some types of cancer, including colon, esophageal, gastric, rectum, , biliary tract, stomach, head and neck, cervical, pancreas, renal cell, and carcinoid. Fluorouracil is an antineoplastic anti-metabolite.

What are the indications for Esgic?

Esgic Capsules (butalbital, acetaminophen and caffeine capsules USP 50 mg/325 mg/40 mg) are indicated for the relief of the symptom complex of tension (or muscle contraction) headache.

What are the indications for nesiritide?

INDICATIONS AND USAGE Natrecor (nesiritide) is indicated for the intravenous treatment of patients with acutely decompensated congestive heart failure who have dyspnea at rest or with minimal activity.

What are the indications for sapropterin?

BH4 deficiencies are more severe than PKU with regard to their response to therapy and treatment is substantially different. Low-Phe diet is not effective and early substitution with dopamine and serotonin precursors, as well as with the synthetic BH4 (sapropterin dihydrochloride) is crucial for a good outcome.

How do you treat BH4 deficiency?

KUVAN (sapropterin dihydrochloride) Tablets for Oral Use and Powder for Oral Solution are prescription medicines used to lower blood Phe levels in adults and children over one month of age with a certain type of Phenylketonuria (PKU). KUVAN is to be used along with a Phe-restricted diet.